A cancer registry is an information system that collects, stores, and manages data on cancer patients. Registries are important in cancer surveillance because they help to recognize the efforts of doctors and scientists as well as where the current treatments stand in terms of reducing the cancer burden. Surveillance data can also be used to plan and evaluate cancer prevention and control interventions, as well as to serve as a foundation for cancer research.
The collection of cancer data begins with identifying cancer patients who have been diagnosed or treated in hospitals, outpatient clinics, radiology departments, doctors' offices, diagnostic laboratories, surgical centers, or other providers (such as pharmacists), who diagnose or treat cancer patients.
Cancer registries collect information that can be classified into several categories such as patient demographics, tumor or cancer characteristics, and stages of disease, treatment and outcomes. To support the handling of information in cancer registries, relevant regulations, policies, and laws are strictly enforced by North American Association for Central Cancer Registries (NAACCR). For example, information identifying a patient is removed when the data is reported. This safeguards cancer patients’ as well as healthcare professional’s’ privacy and confidentiality.
Global Cancer Registry Software Market – Dynamics
The increasing development of cancer registry software in free is expected to boost global cancer registry software market growth. For instance, according to the U.S. Centers for Disease control and Prevention (CDC), by September 2020, over 98% of National Program of Cancer Registries (NPCR)-funded cancer registries used at least one Registry Plus product, with more than half of those used two or more products. Registry Plus is a free software suite for collecting and processing cancer registry data that is available to the public released in March 2020 by CDC. Many cancer registries are now using Registry Plus products as a common platform, allowing them to meet NPCR standards for electronic data exchange, while streamlining and automating registry operations. These factors are expected to support global cancer registry software market growth over the forecast period.
Global Cancer Registry Software Market – Regional Insights
North America may account for the largest share in global cancer registry software market over the forecast period, owing to the rising prevalence of cancer in the U.S. For instance, according to the Centers for Disease Control and Prevention, in 2018, there were 1,708,921 new cases of cancer reported in the U.S., and 599,265 people died from cancer. Moreover, according to the same source, there were 436 new cancer cases reported and 149 people died for every 100,000 people, from cancer in the U.S. Cancer is the second most common cause of death in the U.S., after heart disease. Also, according to the same source, one out of every four deaths in the U.S. is caused by cancer.
Furthermore, due to the increasing launches of new versions of cancer registry software, Europe may witness a lucrative growth in global cancer registry software market over the forecast period. For instance, on 17 June 2019, the Joint Research Center (JRC) of European Commission in collaboration with European Network of Cancer Registries (ENCR) launched the Version 1.8.1 of the JRC – ENCR Cancer Registries Data Quality Check Software including features such as checking on file formats for incidence, mortality and population of cancer patients and checking of primary multiple malignant tumors. These factors are expected to support global cancer registry software market growth over the forecast period.
Global Cancer Registry Software Market – Taxonomy
By Product Type:
By Deployment Model:
By Database Type:
By End User
Global Cancer Registry Software Market – Competitive landscape
Key players operating in the global cancer registry software market include Elekta (Sweden), Onco Inc., CNET Global Solutions, Rocky Mountain Cancer Data Systems (RMCDS), McKesson Corporation, Ordinal data Inc., and Conduent Inc.